These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1401 related items for PubMed ID: 11869942
21. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
23. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Koehler M, Neudorf S. Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008 [Abstract] [Full Text] [Related]
28. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C. Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577 [Abstract] [Full Text] [Related]
30. T cell regeneration in pediatric allogeneic stem cell transplantation. Olkinuora H, Talvensaari K, Kaartinen T, Siitonen S, Saarinen-Pihkala U, Partanen J, Vettenranta K. Bone Marrow Transplant; 2007 Feb; 39(3):149-56. PubMed ID: 17211435 [Abstract] [Full Text] [Related]
31. [Oncology patients in a pediatric intensive care unit--a 7-year experience]. Haase R, Mathony U, Lieser U, Nagel F, Sitka U, Burdach S. Klin Padiatr; 2003 Feb; 215(4):234-40. PubMed ID: 12929015 [Abstract] [Full Text] [Related]
32. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G. Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396 [Abstract] [Full Text] [Related]
33. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS. Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083 [Abstract] [Full Text] [Related]
34. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care. Chima RS, Daniels RC, Kim MO, Li D, Wheeler DS, Davies SM, Jodele S. Pediatr Crit Care Med; 2012 Nov; 13(6):e336-42. PubMed ID: 22791094 [Abstract] [Full Text] [Related]
35. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome. De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R. Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577 [Abstract] [Full Text] [Related]
36. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD. Bone Marrow Transplant; 1998 Apr; 21(7):697-704. PubMed ID: 9578310 [Abstract] [Full Text] [Related]
37. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Cheuk DK, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL, Chan GC. Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390 [Abstract] [Full Text] [Related]
38. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Diaz MA, Vicent MG, Gonzalez ME, Verdeguer A, de la Rubia J, Bargay J, de Arriba F, Diez JL, Caballero D, Madero L, Brunet S, Spanish Group for Allogeneic Peripheral Blood Transplantation. Bone Marrow Transplant; 2004 Sep; 34(5):433-8. PubMed ID: 15273704 [Abstract] [Full Text] [Related]
39. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma. Zhang XH, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Chen YH, Wang JZ, Han W, Lu DP. Chin Med J (Engl); 2007 Mar 20; 120(6):463-8. PubMed ID: 17439737 [Abstract] [Full Text] [Related]
40. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation. Zhu KE, Hu JY, Zhang T, Chen J, Zhong J, Lu YH. Eur J Haematol; 2008 Dec 20; 81(6):461-6. PubMed ID: 18774951 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]